Axol provides human iPSCs and has over 60 lines from healthy and diseased patients for neuronal disease modelling and cardiotoxicity testing. We also provide reprogramming, gene editing and differentiation services for all your iPSC research needs.
Axol Bioscience is a leading provider of human induced pluripotent stem cell (iPSC) technologies, specializing in the manufacture of high-performance iPSC-derived cells and the delivery of industry-leading laboratory services. With over a decade of expertise, Axol partners with global pharmaceutical companies, contract research organizations (CROs), biotechnology firms, start-ups, and academic institutions to advance the use of iPSC-based models in drug discovery and disease research.
We operate across five key areas, neuroscience (including ALS, Alzheimer’s, Huntington’s, Parkinson’s, neuroinflammation), pain & sensation, ophthalmology (Dry-AMD, ophthal-inflammation), dermatology, and cardiovascular.
Axol offers scalable solutions including iPSC banking, reprogramming, gene editing, cell manufacturing, and quality control. The company is committed to closing the translational gap, developing physiologically relevant in vitro systems.
Brands: Axol offers neural stem cells, motor and sensory neurons, astrocytes, microglia and both ventricular and atrial cardiomyocytes. We also offer isogenic controls and can differentiate our own or customer’s iPSCs cells into any cell type of choice.